AnteoTech Ltd is pleased to advise that it has received Conformitè Europëenne (CE) Mark registration for its EuGeni Reader and the in vitro rapid diagnostic test for the detection of SARS-CoV-2 nucleocapsid antigen, the COVID-19 ART.
20210412 Test Platform and COVID-19 Test receive CE Mark approval
